Evaluation of an injury prevention programme (Prep-to-Play) in women and girls playing Australian Football: design of a pragmatic, type III, hybrid implementation-effectiveness, stepped-wedge, cluster randomised controlled trial.
knee
musculoskeletal disorders
orthopaedic sports trauma
sports medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
14 09 2022
14 09 2022
Historique:
entrez:
14
9
2022
pubmed:
15
9
2022
medline:
17
9
2022
Statut:
epublish
Résumé
Due to the increase in participation and risk of anterior cruciate ligament (ACL) injuries and concussion in women's Australian Football, an injury prevention programme (Prep-to-Play) was codesigned with consumers (eg, coaches, players) and stakeholders (eg, the Australian Football League). The impact of supported and unsupported interventions on the use of Prep-to-Play (primary aim) and injury rates (secondary aim) will be evaluated in women and girls playing community Australian Football. This stepped-wedge, cluster randomised controlled trial will include ≥140 teams from U16, U18 or senior women's competitions. All 10 geographically separated clusters (each containing ≥14 teams) will start in the control (unsupported) phase and be randomised to one of five dates (or 'wedges') during the 2021 or 2022 season to sequentially transition to the intervention (supported Prep-to-Play), until all teams receive the intervention. Prep-to-Play includes four elements: a neuromuscular training warm-up, contact-focussed football skills (eg, tackling), strength exercises and education (eg, technique cues). When transitioning to supported interventions, study physiotherapists will deliver a workshop to coaches and player leaders on how to use Prep-to-Play, attend team training at least two times and provide ongoing support. In the unsupported phase, team will continue usual routines and may freely access available Prep-to-Play resources online (eg, posters and videos about the four elements), but without additional face-to-face support. Outcomes will be evaluated throughout the 2021 and 2022 seasons (~14 weeks per season). use of Prep-to-Play will be reported via a team designate (weekly) and an independent observer (five visits over the two seasons) and defined as the team completing 75% of the programme, two-thirds (67%) of the time. injuries will be reported by the team sports trainer and/or players. Injury definition: any injury occurring during a football match or training that results in: (1) being unable to return to the field of play for that match or (2) missing ≥ one match. Outcomes in the supported and unsupported phases will be compared using a generalised linear mixed model adjusting for clustering and time. Due to the type III hybrid implementation-effectiveness design, the study is powered to detect a improvement in use of Prep-to-Play La Trobe University Ethics Committee (HREC 20488) approved. Coaches provided informed consent to receive the supported intervention and players provided consent to be contacted if they sustained a head or knee injury. Results will be disseminated through partner organisations, peer-reviewed publications and scientific conferences. NCT04856241.
Identifiants
pubmed: 36104145
pii: bmjopen-2022-062483
doi: 10.1136/bmjopen-2022-062483
pmc: PMC9476120
doi:
Banques de données
ClinicalTrials.gov
['NCT04856241']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e062483Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: MM is employed by the AFL as Chief Medical Officer. The partner organisations assisted with the intervention design (AFL) and participant recruitment (AFL, AFL Victoria, Medibank, APA) but will not be involved in collecting, managing, analysing the data or deciding to submit for publication.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Scand J Med Sci Sports. 2008 Oct;18(5):605-14
pubmed: 18208428
Br J Sports Med. 2020 Jan;54(1):51-57
pubmed: 31511232
Br J Sports Med. 2014 Nov;48(21):1543-52
pubmed: 25157180
Clin Neuropsychol. 2019 Aug;33(6):1016-1043
pubmed: 30618335
Br J Sports Med. 2020 Apr;54(7):372-389
pubmed: 32071062
Am J Sports Med. 2014 May;42(5):1247-55
pubmed: 24318609
Am J Sports Med. 2018 Oct;46(12):2873-2883
pubmed: 30179520
Br J Sports Med. 2011 Dec;45(16):1253-7
pubmed: 21697220
Inj Prev. 2016 Apr;22(2):123-8
pubmed: 26399611
J Sci Med Sport. 2019 Jun;22(6):629-634
pubmed: 30587436
Br J Sports Med. 2013 May;47(8):473-5
pubmed: 23501832
Br J Sports Med. 2020 Sep;54(18):1089-1098
pubmed: 32253193
Sports Med. 2016 Aug;46(8):1125-39
pubmed: 26869058
J Med Internet Res. 2016 Jan 04;18(1):e2
pubmed: 26729058
BMJ. 2012 May 03;344:e3042
pubmed: 22556050
J Sports Sci. 2020 Oct;38(20):2329-2337
pubmed: 32588750
Br J Sports Med. 2022 Jul;56(14):812-817
pubmed: 35387776
J Sci Med Sport. 2015 May;18(3):272-7
pubmed: 24930985
J Sci Med Sport. 2020 Apr;23(4):353-360
pubmed: 31734167
J Sci Med Sport. 2005 Sep;8(3):294-304
pubmed: 16248470
Sports Med. 2018 Apr;48(4):953-969
pubmed: 29349651
Br J Sports Med. 2017 Jun;51(12):958-968
pubmed: 28483928
J Athl Train. 2012 Nov-Dec;47(6):714-23
pubmed: 23182020
J Orthop Sports Phys Ther. 2018 Sep;48(9):A1-A42
pubmed: 30170521
Contemp Clin Trials. 2007 Feb;28(2):182-91
pubmed: 16829207
Sports Med. 2019 Oct;49(10):1515-1528
pubmed: 31187453
Br J Sports Med. 2012 Apr;46(5):306-7
pubmed: 22006931
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
J Sport Health Sci. 2016 Sep;5(3):334-341
pubmed: 30356506
Br J Sports Med. 2013 May;47(8):480-7
pubmed: 23486935
Arthritis Care Res (Hoboken). 2020 Mar;72(3):412-422
pubmed: 30762314
Am J Sports Med. 2010 Jul;38(7):1334-42
pubmed: 20410376
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Br J Sports Med. 2017 Jun;51(12):969-977
pubmed: 28455362
Int J Epidemiol. 2020 Jun 1;49(3):979-995
pubmed: 32087011
Br J Sports Med. 2020 Aug;54(15):913-919
pubmed: 31822477
J Sport Health Sci. 2021 Sep 20;:
pubmed: 34547480
J Sport Health Sci. 2019 Jan;8(1):8-16
pubmed: 30719378
BMJ Open Sport Exerc Med. 2016 Jul 5;2(1):e000101
pubmed: 27900171
Sports Med. 2021 Dec;51(12):2461-2467
pubmed: 34533777
Br J Sports Med. 2019 Nov;53(21):1333-1340
pubmed: 29599121
Br J Sports Med. 2014 Oct;48(19):1425-30
pubmed: 24850618
BMJ Open Sport Exerc Med. 2016 Apr 13;2(1):e000112
pubmed: 27900178
Br J Sports Med. 2013 Aug;47(12):794-802
pubmed: 23559666
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Br J Sports Med. 2018 Sep;52(18):1179-1190
pubmed: 28735282
BMJ. 2015 Jun 08;350:h2925
pubmed: 26055828
Br J Sports Med. 2020 Sep;54(17):1028-1035
pubmed: 31992545
Am J Epidemiol. 1999 May 1;149(9):876-83
pubmed: 10221325
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Br J Sports Med. 2012 Nov;46(14):979-88
pubmed: 22745221
Clin J Sport Med. 2018 Jul;28(4):325-331
pubmed: 29864071
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
J Athl Train. 2019 May;54(5):472-482
pubmed: 31009238
Br J Sports Med. 2017 Aug;51(15):1140-1146
pubmed: 28515056
BMJ Open. 2020 Nov 3;10(11):e034696
pubmed: 33148720
Braz J Phys Ther. 2021 Nov-Dec;25(6):756-766
pubmed: 34120837
J Sci Med Sport. 2009 Jul;12(4):452-6
pubmed: 18768361
Br J Sports Med. 2014 Jan;48(2):91-7
pubmed: 24052371
BMJ. 2018 Nov 9;363:k1614
pubmed: 30413417